◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Ono Pharmaceutical Co., Ltd. (4528) Financial History

Name: Ono Pharmaceutical Co., Ltd. (4528) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - General · DATA UPDATED 2026-08-11

Ono Pharmaceutical Co., Ltd. (4528) operates in the Drug Manufacturers - General industry and is headquartered in Osaka, Japan with about 4,206 employees. Its market capitalization is roughly JPY 1.14 trillion. In the fiscal year ended 2026-03-31, 4528 reported JPY 515.8B in revenue and JPY 69.8B in net income.

Ono Pharmaceutical Co., Ltd. produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.

Interactive charts & full statements →

4528 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 515.8B	JPY 486.9B	JPY 502.7B	JPY 447.2B
Gross Profit	JPY 374.1B	JPY 338.9B	JPY 375.5B	JPY 337.1B
Operating Income (EBIT)	JPY 92.2B	JPY 59.7B	JPY 159.9B	JPY 142.0B
Net Income	JPY 69.8B	JPY 50.0B	JPY 128.0B	JPY 112.7B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4528 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 37.5B)	(JPY 37.5B)	(JPY 37.2B)	(JPY 29.7B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4528 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 1.11T	JPY 1.06T	JPY 913.7B	JPY 882.4B	—
Total Liabilities	JPY 249.9B	JPY 275.8B	JPY 115.1B	JPY 134.6B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4528 viewer.

4528 Metric Deep Dives

Other Companies in Drug Manufacturers - General

4519 · Chugai Pharmaceutical Co., Ltd. — $11.70 trillion
4578 · Otsuka Holdings Co., Ltd. — $6.60 trillion
4568 · Daiichi Sankyo Company, Limited — $5.10 trillion
4503 · Astellas Pharma Inc. — $4.24 trillion
4536 · Santen Pharmaceutical Co., Ltd. — $625 billion
NOVN · Novartis AG — $233 billion
1093 · CSPC Pharmaceutical Group Limited — $98 billion
GSK · GSK plc — $73 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4527 All “0-9” companies 4531 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.